ljc 10627 has been researched along with tebipenem in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Distèche-Nguyen, M; Gerards, T; Luxen, A; Miguet, L; Pasha, FA; Thomas, A; Zervosen, A | 1 |
| Bell, DT; Culhane, JC; Ebner, DC; Heuer, AM; Ippoliti, JT; Kaushik, A; Lamichhane, G; Parrish, N | 1 |
| Baba, N; Gomi, S; Ohsawa, F; Takeuchi, Y; Watanabe, T; Yamada, M | 1 |
| Basta, LAB; Bianchet, MA; Kumar, P; Lamichhane, G; Lloyd, EP; Mattoo, R; Pan, YH; Saavedra, H; Townsend, CA | 1 |
4 other study(ies) available for ljc 10627 and tebipenem
| Article | Year |
|---|---|
Discovery of new inhibitors of resistant Streptococcus pneumoniae penicillin binding protein (PBP) 2x by structure-based virtual screening.
Topics: Computational Biology; Computer Simulation; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Ligands; Penicillin-Binding Proteins; Protein Binding; Streptococcus pneumoniae; Structure-Activity Relationship | 2009 |
An evolved oxazolidinone with selective potency against Mycobacterium tuberculosis and gram positive bacteria.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Structure-Activity Relationship | 2016 |
Crystal structures of biapenem and tebipenem complexed with penicillin-binding proteins 2X and 1A from Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Binding Sites; Carbapenems; Crystallization; Crystallography, X-Ray; Models, Molecular; Molecular Structure; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding; Streptococcus pneumoniae; Thienamycins | 2008 |
Structural insight into the inactivation of Mycobacterium tuberculosis non-classical transpeptidase Ldt
Topics: beta-Lactams; Carbapenems; Crystallography, X-Ray; Drug Design; Mycobacterium tuberculosis; Peptidyl Transferases; Protein Binding; Thienamycins | 2017 |